EntryPoint Capital’s Humana HUM Stock Holding History

EntryPoint Capital’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-97	Closed	-$44.4K	–	1571
2023 Q4	$44.4K	Buy	+97	New	+$47.8K	0.04%	787

Other funds holding HUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

EntryPoint Capital's HUM Position: Q1 2024 in Review

EntryPoint Capital sold out of Humana (HUM) in Q1 2024, closing a stake of 97 shares — an estimated $44.4K sold.

EntryPoint Capital first reported a position in HUM in Q4 2023 and held it in 1 quarter. The position peaked at $44.4K in Q4 2023. 1,029 funds tracked by Wall St. Rank hold HUM as of Q1 2024.

EntryPoint Capital reported no remaining Humana position as of Q1 2024 after selling out during the quarter.
EntryPoint Capital sold 97 Humana shares in Q1 2024, an estimated $44.4K.
EntryPoint Capital first reported a position in Humana in Q4 2023 and held it in 1 quarter.
EntryPoint Capital's Humana position peaked at $44.4K in Q4 2023.
1,029 funds tracked by Wall St. Rank held Humana as of Q1 2024.

Based on EntryPoint Capital's 13F filing for Q1 2024, filed 14 May 2024.